Platinum-Refractory Ovarian Carcinoma

Explore clinical trials studying Platinum-Refractory Ovarian Carcinoma. Study availability and eligibility vary by location and protocol.

5 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Platinum-Refractory Ovarian Carcinoma trial results

Recruiting

NCT06586957

Conditions: Adnexal Diseases, Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, +62 more
Locations: University of Arkansas Medical School Little Rock, Arkansas, United States

University of California - Los Angeles Los Angeles, California, United States

UCSF San Francisco, California, United States

SCRI at HealthOne Denver, Colorado, United States

View all 19 locations

Completed

NCT03508570

Conditions: Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +58 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

Completed

NCT02835833

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +25 more
Locations: University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States

Active, Not Recruiting

NCT04739800

Conditions: Fallopian Tube Mucinous Adenocarcinoma, Ovarian Seromucinous Carcinoma, Platinum-Refractory Fallopian Tube Carcinoma, +47 more
Locations: Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States

Alaska Oncology and Hematology LLC Anchorage, Alaska, United States

View all 392 locations

Active, Not Recruiting

NCT05271318

Conditions: Adenoviridae Infections, DNA Virus Infections, Infections, +10 more
Locations: Mayo Clinic Rochester, Minnesota, United States

Northwell Heatlh/Lenox Hill Hospital New York, United States

Docrates Cancer Center Helsinki, Finland